Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ELI LILLY & Co Director's Dealing 2023

Feb 14, 2023

29745_dirs_2023-02-14_8be058b0-582d-4ccd-ab6c-e281a0330d33.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-02-10

Reporting Person: Hakim Anat (EVP, GC & Secretary)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-02-10 Common Stock A 9072 $345.12 Acquired 22189 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-02-10 Restricted Stock Unit $ A 4442 Acquired 2024-02-01 Common Stock (4442.0) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.